What is INGN's last price and market cap on Chartloom?

The overview shows a last price near n/a and market cap near 0.16B (subject to data latency), alongside the price snapshot and profile on this page.

What P/E and 52-week range are shown for INGN?

P/E (TTM) is n/a and 52-week range is $5.04 to $9.13 when available from the data feed; see the metrics and chart on this page.

Where do Chartloom’s INGN figures come from?

Figures are compiled from market data and SEC-backed fundamentals used in the app. Use primary filings and a broker for trading decisions.

What trailing-twelve-month financials does Chartloom show for INGN?

The company profile lists revenue (TTM) near $355M, net income (TTM) near $-2.46B, EPS (TTM) near $-0.90 when available from the market-data feed. Figures are informational and may lag live markets.

Where is Inogen Inc based, and what identifiers does Chartloom list?

The company context section lists headquarters in Goleta, California, US, 27.1M shares outstanding, ISIN US45780L1044 when available from company profile and filing metadata.

Inogen Inc

$INGN

Health Care · Health Care Equipment & Supplies

IR Run Scenarios

$6.18

+4.04%

Overview AI Summary Charts Financials Valuation

Profile

Read AI summary

Inogen, Inc. is a global medical technology company offering innovative respiratory products for use in the homecare setting. The company is headquartered in Goleta, California and currently employs 753 full-time employees. The company went IPO on 2014-02-14. The firm partners with patients, prescribers, home medical equipment providers, and distributors to make its respiratory therapy products available. The company develops, manufactures, and markets respiratory health products, including portable oxygen concentrators (POCs), used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions and the Simeox product for airway clearance treatment. The company also distributes the Inogen Voxi 5 stationary oxygen concentrator as well as the Aurora continuous positive airway pressure (CPAP) masks in the United States. Its proprietary Inogen One and Inogen Rove POC systems concentrate the air around the patient to offer a source of supplemental oxygen 24 hours a day, seven days a week with a battery and can be plugged into an outlet when at home, in a car, or in a public place with outlets available.

Employees

753

Website

www.inogen.com/

IPO

2014-02-14

Beta

Next earnings date

—

Financials & valuation

Open valuation

Revenue (TTM)